Autonomix Medical, Inc. SEC filings AMIX
Autonomix Medical, Inc. has 149 filings in SEC EDGAR's recent list, going back to Sep 3, 2014. Its latest annual report, Form 10-K, was filed on May 27, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 3, 2026 | Oct 29, 2026 |
| 424B3 | Prospectus | Sep 16, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2026 | Sep 14, 2026 |
| EFFECT | Filing | Sep 15, 2026 | — |
| DEFA14A | Additional proxy material | Sep 14, 2026 | — |
| DEF 14A | Proxy statement | Sep 14, 2026 | Oct 29, 2026 |
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| PRE 14A | Preliminary proxy statement | Sep 4, 2026 | Oct 29, 2026 |
| S-3 | Shelf registration | Sep 4, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 26, 2026 | Aug 24, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Aug 4, 2026 | — |
| 424B5 | Prospectus supplement | Jul 31, 2026 | — |
| S-3 | Shelf registration | Jul 28, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 15, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Other events
|
Jul 10, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 24, 2026 | Jun 18, 2026 |
| 10-K/A | Amended annual report | Jun 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | May 27, 2026 | Mar 31, 2026 |
| S-8 | Employee stock plan registration | Apr 2, 2026 | — |
| 10-Q | Quarterly report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 16, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 424B3 | Prospectus | Dec 12, 2025 | — |
| EFFECT | Filing | Dec 11, 2025 | — |
| CORRESP | Letter to the SEC | Dec 9, 2025 | — |
| S-3 | Shelf registration | Nov 26, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 19, 2025 | Nov 18, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Nov 3, 2025 | Oct 30, 2025 |
| 424B3 | Prospectus | Oct 6, 2025 | — |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| S-1 | Registration statement | Sep 23, 2025 | — |
| DEFA14A | Additional proxy material | Sep 12, 2025 | — |
| DEF 14A | Proxy statement | Sep 12, 2025 | Oct 30, 2025 |
| 424B3 | Prospectus | Sep 11, 2025 | — |
| EFFECT | Filing | Sep 8, 2025 | — |
| CORRESP | Letter to the SEC | Sep 4, 2025 | — |
| S-1/A | Amended registration statement | Sep 3, 2025 | — |
| PRE 14A | Preliminary proxy statement | Aug 29, 2025 | Oct 30, 2025 |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 27, 2025 | Aug 25, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 26, 2025 | Aug 25, 2025 |
| 424B5 | Prospectus supplement | Aug 25, 2025 | — |
| S-1 | Registration statement | Aug 20, 2025 | — |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-K/A | Amended annual report | Jul 28, 2025 | Mar 31, 2025 |
| 424B3 | Prospectus | Jul 23, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 22, 2025 | Jul 21, 2025 |
| EFFECT | Filing | Jul 11, 2025 | — |
| POS AM | Filing | Jul 3, 2025 | — |
| 10-K | Annual report | May 29, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 30, 2025 | Apr 30, 2025 |
| EFFECT | Filing | Mar 11, 2025 | — |
| CORRESP | Letter to the SEC | Mar 10, 2025 | — |
| S-3/A | Form s-3/a | Mar 7, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2025 | — |
| S-3 | Shelf registration | Feb 28, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2025 | Feb 13, 2025 |
| 10-Q | Quarterly report | Feb 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 22, 2025 | Jan 22, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 25, 2024 | Nov 22, 2024 |
| 424B4 | Prospectus | Nov 25, 2024 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 19, 2024 | — |
| CORRESP | Letter to the SEC | Nov 19, 2024 | — |
| S-1/A | Amended registration statement | Nov 12, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 11, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Nov 4, 2024 | Nov 4, 2024 |
| S-1 | Registration statement | Nov 1, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Oct 28, 2024 | Oct 22, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 17, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 20, 2024 | Sep 16, 2024 |
| DEFA14A | Additional proxy material | Sep 5, 2024 | — |
| DEF 14A | Proxy statement | Sep 4, 2024 | Oct 17, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 23, 2024 | Oct 17, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| UPLOAD | Letter from the SEC | Aug 2, 2024 | — |
| 10-K/A | Amended annual report | Jul 26, 2024 | Mar 31, 2024 |
| DRS | Filing | Jul 26, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 15, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2024 | Jun 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Jun 17, 2024 | Jun 17, 2024 |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| 10-K | Annual report | May 31, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 31, 2024 | May 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Feb 29, 2024 |
| 10-Q | Quarterly report | Feb 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 31, 2024 | Jan 26, 2024 |
| CERT | Filing | Jan 26, 2024 | — |
| 8-A12B | Form 8-a | Jan 26, 2024 | — |
| 253G2 | Filing | Jan 26, 2024 | — |
| QUALIF | Filing | Jan 25, 2024 | — |
| 1-A POS | Filing | Jan 19, 2024 | — |
| 253G2 | Offering circular | Jan 11, 2024 | — |
| 1-SA | Filing | Jan 9, 2024 | Sep 30, 2023 |
| 253G2 | Offering circular | Oct 16, 2023 | — |
| QUALIF | Filing | Sep 29, 2023 | — |
| 1-A/A | Filing | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 15, 2023 | — |
| 1-A/A | Filing | Sep 15, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| 1-A/A | Filing | Aug 22, 2023 | — |
| CORRESP | Letter to the SEC | Aug 21, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2023 | — |
| 1-A | Filing | Jul 7, 2023 | — |
| D | Filing | Jun 1, 2023 | — |
| D | Filing | Mar 20, 2023 | — |
| D | Filing | Apr 6, 2022 | — |
| D | Filing | Sep 3, 2014 | — |
Showing 117 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AMIX (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- The Woodlands, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1617867
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.